By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


Big Pharma


CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.


Maxygen, Inc. 

Intergen Company 

Company News
Novo Nordisk A/S (NVO) To Feature In New Groundbreaking Cambridge University Students' Union Project 2/2/2016 1:52:49 PM
Novo Nordisk A/S (NVO) Launches Tresiba (insulin Degludec Injection 200 Units/Ml) In The United States 1/26/2016 6:30:47 AM
Novo Nordisk A/S (NVO), IBM (IBM) Join Forces to Create a Virtual Doctor 12/10/2015 6:26:22 AM
Novo Nordisk A/S (NVO) Files For Regulatory Approval Of "Faster-Acting Insulin Aspart" In The U.S. 12/9/2015 7:28:40 AM
Novo Nordisk A/S (NVO) Breathes New Life into XOMA  (XOMA) with $295 Million Diabetes Pact 12/1/2015 7:05:32 AM
Ablynx (ABLYF), Novo Nordisk A/S (NVO) Ink Nanobody Pact Worth $399 Million+ 11/25/2015 10:07:32 AM
Novo Nordisk A/S (NVO) Release: Emerging Data Could Begin To Redefine How Cities Address The Growing Diabetes Epidemic 11/10/2015 10:52:49 AM
Great Place To Work And Fortune Name Novo Nordisk A/S (NVO) As One Of The 50 Best Workplaces For Diversity In US 11/10/2015 10:21:40 AM
Novo Nordisk A/S (NVO) Release: Data Presented At ObesityWeek Showed Saxenda (liraglutide [rDNA origin] injection) Treatment Demonstrated Significant And Sustained Weight Loss Over Three Years Compared With Placebo 11/4/2015 11:51:08 AM
Emisphere (EMIS), Novo Nordisk A/S (NVO) Ink $221 Million+ Deal Develop Oral Formulations of Four Molecules Targeting Metabolic Indications 10/15/2015 6:52:41 AM